GO:0006693 prostaglandin metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006693 (prostaglandin metabolic process) describes the chemical reactions and pathways involving prostaglandins, biologically active metabolites that contain a cyclopentane ring formed by bonding between two carbons of a fatty acid.
• Prostaglandins are synthesized from arachidonic acid via cyclooxygenase (COX) enzymes and act as local hormones with a wide range of biological activities.
• Prostaglandin metabolism is central to inflammation, pain, fever, and reproductive processes, and is a major target of nonsteroidal anti-inflammatory drugs.
• Transcellular biosynthesis allows prostaglandins to be produced cooperatively by different cell types, amplifying their effects in tissues.
• Dysregulated prostaglandin metabolism is implicated in cancer, cardiovascular disease, and reproductive disorders.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of prostaglandin pathway genes in disease and physiology.
Description
Prostaglandins are a family of lipid mediators derived from arachidonic acid that play pivotal roles in inflammation, pain, fever, and reproduction. The Gene Ontology term GO:0006693, prostaglandin metabolic process, encompasses all chemical reactions and pathways involving these molecules, from their synthesis to their degradation. Understanding this process is fundamental for researchers studying inflammatory diseases, cancer, and reproductive biology. The pathway involves a series of enzymatic steps, including the action of cyclooxygenases (COX-1 and COX-2) and terminal prostaglandin synthases, which convert arachidonic acid into various prostaglandin species such as PGE2, PGF2α, PGI2, and TXA2. These metabolites exert their effects through G-protein-coupled receptors, leading to diverse physiological and pathological outcomes. Given the clinical importance of prostaglandins, targeting their metabolic pathways is a major therapeutic strategy, and CRISPR-based gene editing offers powerful tools to study these processes.
prostaglandin metabolic process At A Glance
| GO ID | GO:0006693 |
|---|---|
| GO term | prostaglandin metabolic process |
| Ontology | biological_process |
| Synonym | prostaglandin metabolism |
| Major function | Synthesis, interconversion, and degradation of prostaglandins, which are lipid mediators with diverse biological activities |
| Key enzymes | Cyclooxygenases (PTGS1, PTGS2), prostaglandin synthases (e.g., PTGES, PTGIS, PTGDS, TBXAS1) |
| Substrates | Arachidonic acid and other polyunsaturated fatty acids |
| Pathological relevance | Inflammation, cancer, cardiovascular disease, reproductive disorders |
What Is GO:0006693?
GO:0006693, prostaglandin metabolic process, is defined as the chemical reactions and pathways involving prostaglandins, which are biologically active metabolites containing a cyclopentane ring formed by a bond between two carbons of a fatty acid. This process includes the biosynthesis of prostaglandins from precursor fatty acids, their interconversion, and their degradation. Prostaglandins act as local hormones and are involved in a wide range of biological activities, including inflammation, pain, fever, and regulation of smooth muscle tone.
Why Is prostaglandin metabolic process Important in Cell Biology?
Prostaglandin metabolic process is critically important because prostaglandins regulate fundamental physiological processes such as inflammation, pain perception, fever, blood clotting, and parturition. Dysregulation of this pathway contributes to numerous diseases, including cancer, where prostaglandins promote tumor growth and metastasis, and reproductive disorders, where they affect endometrial receptivity and ovulation. Moreover, prostaglandins are targets of widely used drugs like NSAIDs, underscoring their clinical significance. Research into this pathway is essential for developing new therapeutic strategies and understanding the molecular basis of inflammatory and metabolic diseases.
• Prostaglandins mediate inflammation, pain, and fever, making this pathway a key target for anti-inflammatory drugs.
• They play essential roles in female reproduction, including ovulation, implantation, and labor.
• Prostaglandins regulate vascular tone and platelet aggregation, impacting cardiovascular health.
• Dysregulated prostaglandin metabolism is linked to cancer progression and metastasis.
• Transcellular biosynthesis of prostaglandins allows cooperative production between different cell types, amplifying biological effects.
• Prostaglandin hyperalgesia is a metabolic process that sensitizes nociceptors, contributing to chronic pain.
• Genetic variations in prostaglandin pathway genes influence susceptibility to inflammatory diseases.
• Understanding prostaglandin metabolism aids in the development of targeted therapies with fewer side effects.
• Prostaglandins are involved in kidney function and blood pressure regulation.
• CRISPR screening can identify novel regulators of prostaglandin metabolism for therapeutic intervention.
What Happens During prostaglandin metabolic process?
Release of Arachidonic Acid
In simple terms: The process starts when a fatty acid called arachidonic acid is freed from cell membranes.
Prostaglandin synthesis begins with the release of arachidonic acid from membrane phospholipids by phospholipase A2 (PLA2) enzymes. This step is rate-limiting and is regulated by various stimuli, including hormones and inflammatory signals. The free arachidonic acid then serves as the substrate for cyclooxygenase enzymes.
Cyclooxygenase-Mediated Conversion
In simple terms: Enzymes called cyclooxygenases convert arachidonic acid into unstable intermediates.
Cyclooxygenase enzymes, COX-1 (PTGS1) and COX-2 (PTGS2), catalyze the conversion of arachidonic acid to prostaglandin G2 (PGG2) and then to prostaglandin H2 (PGH2). PGH2 is the common precursor for all prostaglandins. COX-1 is constitutively expressed in most tissues, while COX-2 is induced by inflammatory stimuli.
Terminal Synthase Reactions
In simple terms: Specific enzymes turn the common precursor into different prostaglandins.
PGH2 is converted by specific terminal synthases into biologically active prostaglandins: PGE2 by PTGES, PGD2 by PTGDS, PGF2α by PTGFS, PGI2 by PTGIS, and TXA2 by TBXAS1. Each prostaglandin has distinct biological activities and acts through specific receptors.
Transcellular Biosynthesis
In simple terms: Different cells can cooperate to produce prostaglandins.
Transcellular biosynthesis allows prostaglandins to be produced through the cooperation of different cell types. For example, endothelial cells can use PGH2 released by platelets to produce PGI2. This mechanism amplifies prostaglandin production and diversifies their effects in tissues.
Degradation and Inactivation
In simple terms: Prostaglandins are broken down to stop their signals.
Prostaglandins are rapidly metabolized to inactive metabolites. For instance, PGE2 is converted to 15-keto-PGE2 by 15-hydroxyprostaglandin dehydrogenase (15-PGDH), which is further metabolized and excreted. This degradation ensures tight regulation of prostaglandin signaling.
Key Genes Involved in GO:0006693 prostaglandin metabolic process
The following genes encode key enzymes and proteins involved in prostaglandin metabolic process, from arachidonic acid release to prostaglandin synthesis and degradation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLA2G4A | Phospholipase A2, releases arachidonic acid from membranes | Rate-limiting step in prostaglandin synthesis; target for anti-inflammatory drugs |
| PTGS1 | Cyclooxygenase-1, constitutive enzyme producing prostaglandins | Maintains gastric mucosal integrity and platelet function; target of aspirin |
| PTGS2 | Cyclooxygenase-2, inducible enzyme in inflammation | Key target of NSAIDs; overexpressed in many cancers |
| PTGES | Prostaglandin E synthase, converts PGH2 to PGE2 | PGE2 is a major mediator of inflammation and cancer progression |
| PTGDS | Prostaglandin D synthase, produces PGD2 | PGD2 involved in sleep regulation and allergic responses |
| PTGIS | Prostacyclin synthase, produces PGI2 | PGI2 is a vasodilator and inhibitor of platelet aggregation |
| TBXAS1 | Thromboxane A synthase, produces TXA2 | TXA2 promotes platelet aggregation and vasoconstriction |
| HPGD | 15-hydroxyprostaglandin dehydrogenase, degrades prostaglandins | Regulates prostaglandin levels; tumor suppressor in some cancers |
| PTGFR | Prostaglandin F receptor | Mediates PGF2α effects in reproduction and smooth muscle contraction |
| PTGER1 | Prostaglandin E receptor 1 | Involved in pain and fever |
| PTGER2 | Prostaglandin E receptor 2 | Regulates inflammation and immune responses |
| PTGER3 | Prostaglandin E receptor 3 | Modulates pain perception and gastric secretion |
| PTGER4 | Prostaglandin E receptor 4 | Promotes tumor progression and immune suppression |
| PTGIR | Prostacyclin receptor | Mediates vasodilation and anti-thrombotic effects |
| TBXA2R | Thromboxane A2 receptor | Mediates vasoconstriction and platelet activation |
| CBR1 | Carbonyl reductase 1, metabolizes prostaglandins | Inactivates PGE2 and other prostaglandins |
| AKR1C3 | Aldo-keto reductase family 1 member C3, prostaglandin synthesis | Produces PGF2α and PGE2; implicated in cancer |
| SLC02A1 | Prostaglandin transporter | Uptake of prostaglandins for degradation |
How Is prostaglandin metabolic process Regulated?
Prostaglandin metabolic process is regulated at multiple levels. The release of arachidonic acid by PLA2 is controlled by calcium and phosphorylation. COX-2 expression is induced by inflammatory cytokines, growth factors, and tumor promoters, while COX-1 is constitutively expressed. Terminal synthases are differentially expressed and regulated, determining the profile of prostaglandins produced. Degradation by 15-PGDH is also regulated, affecting prostaglandin half-life. Additionally, transcellular biosynthesis provides a mechanism for intercellular regulation.
prostaglandin metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTGS2 | Colorectal cancer, inflammation | Knockout or overexpression in cancer cell lines |
| PTGES | Cancer progression, inflammation | Knockdown or knockout in tumor models |
| HPGD | Cancer, prostaglandin degradation | Overexpression or knockout to study tumor suppression |
| PTGFR | Reproductive disorders | Knockout in mouse models to study implantation |
| TBXAS1 | Cardiovascular disease | Point mutation or knockout to assess thrombosis |
Prostaglandins in Cancer
Prostaglandins, particularly PGE2, promote tumor growth, angiogenesis, and metastasis. Overexpression of COX-2 and PTGES is observed in many cancers, including colorectal, breast, and lung cancer. PGE2 suppresses immune surveillance and enhances cancer cell proliferation. Targeting prostaglandin synthesis with NSAIDs or selective COX-2 inhibitors reduces cancer risk in some populations.
Prostaglandins in Reproductive Disorders
Prostaglandins are critical for ovulation, implantation, and parturition. Dysregulated prostaglandin metabolism is associated with endometriosis, recurrent miscarriage, and preterm labor. For example, altered expression of PTGS2 and PTGFR in the endometrium affects receptivity. Understanding these pathways may lead to new treatments for infertility.
Prostaglandins in Cardiovascular Disease
The balance between prostacyclin (PGI2) and thromboxane A2 (TXA2) is crucial for cardiovascular homeostasis. An imbalance contributes to thrombosis, hypertension, and atherosclerosis. Low-dose aspirin inhibits COX-1, shifting the balance toward PGI2 and reducing cardiovascular events.
Prostaglandins in Pain and Inflammation
Prostaglandins sensitize nociceptors, leading to hyperalgesia and pain. They also mediate fever and inflammation. NSAIDs, which inhibit COX enzymes, are widely used to treat pain and inflammation. Prostaglandin hyperalgesia is a metabolic process involving the release of prostaglandins at sites of tissue injury.
From prostaglandin metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PTGS2 knockout reduce tumor growth? | PTGS2 knockout cancer cell lines or mouse models |
| What is the effect of a specific PTGES point mutation on enzyme activity? | Point mutation knock-in cell lines |
| Can overexpression of HPGD suppress prostaglandin levels? | HPGD overexpression cell lines |
| How does PTGFR signaling affect implantation? | PTGFR knockout mouse models |
| What is the role of TBXAS1 in platelet aggregation? | TBXAS1 knockout or point mutation in platelets |
| Can CRISPR screening identify novel regulators of prostaglandin synthesis? | Genome-wide CRISPR knockout library in relevant cells |
How to Study the prostaglandin metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality or regulation of prostaglandin production | Identify novel regulators |
| Lipidomics (LC-MS/MS) | Prostaglandin levels | Quantify pathway output |
| RNA-seq | Gene expression changes | Assess transcriptional regulation |
| Western blot | Protein expression and modification | Validate enzyme levels |
| Immunohistochemistry | Tissue localization of enzymes | Study expression in disease tissues |
| Enzyme activity assay | Catalytic activity of COX or synthases | Measure effects of mutations |
| CRISPR knock-in | Introduction of specific mutations | Model disease variants |
| Flow cytometry | Cell surface receptor expression | Analyze prostaglandin receptors |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate prostaglandin production. For example, screening for regulators of PGE2 secretion can reveal novel targets in inflammation and cancer. These screens use pooled sgRNA libraries and next-generation sequencing to quantify gene effects.
Targeted Gene Editing
CRISPR-Cas9 can create knockout, point mutation, or knock-in models to study specific prostaglandin pathway genes. For instance, knocking out PTGS2 in cancer cells can validate its role in tumor growth. Point mutations can mimic disease-associated variants.
Metabolite Profiling
Mass spectrometry-based lipidomics can quantify prostaglandin levels in cells and tissues. This method measures the output of the metabolic pathway and can be used to assess the impact of genetic perturbations.
Expression Analysis
RNA-seq and qPCR can measure the expression of prostaglandin pathway genes under different conditions. This helps identify transcriptional regulation and splice variants.
How CRISPR Can Be Used to Study GO:0006693 prostaglandin metabolic process
Knockout
CRISPR knockout of prostaglandin pathway genes, such as PTGS2 or PTGES, can abolish prostaglandin production and reveal their roles in inflammation, cancer, and reproduction. Knockout cell lines are valuable for drug target validation.
Point Mutation
Point mutations can be introduced to mimic naturally occurring variants or to dissect catalytic residues. For example, mutating the active site of PTGS2 can clarify its mechanism. These models help understand how specific mutations affect enzyme activity and disease risk.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP) allows real-time tracking of prostaglandin enzymes. Tagged knock-in of PTGES can reveal its subcellular localization and dynamics. Knock-in of disease-associated mutations can model human conditions.
Overexpression
Overexpression of prostaglandin synthases or receptors can amplify pathway activity and study gain-of-function effects. For instance, overexpressing PTGES increases PGE2 production and promotes tumor growth. Overexpression models are useful for screening inhibitors.
How EDITGENE Supports prostaglandin metabolic process Research
Researchers studying prostaglandin metabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation or disease. EDITGENE provides comprehensive CRISPR services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for prostaglandin metabolic process research.
Frequently Asked Questions About prostaglandin metabolic process
What is prostaglandin metabolic process?
Prostaglandin metabolic process (GO:0006693) encompasses the chemical reactions and pathways involving prostaglandins, which are biologically active metabolites containing a cyclopentane ring formed from fatty acids.
What genes are involved in prostaglandin metabolic process?
Key genes include PTGS1, PTGS2, PTGES, PTGDS, PTGIS, TBXAS1, HPGD, and various prostaglandin receptors such as PTGER1-4.
How are prostaglandins synthesized?
Prostaglandins are synthesized from arachidonic acid released by PLA2, converted by COX enzymes to PGH2, and then to specific prostaglandins by terminal synthases.
What is the role of prostaglandins in inflammation?
Prostaglandins mediate inflammation, pain, and fever by sensitizing nociceptors and promoting vasodilation.
How are prostaglandins degraded?
Prostaglandins are degraded by enzymes like 15-hydroxyprostaglandin dehydrogenase (HPGD) to inactive metabolites.
What diseases are associated with prostaglandin metabolism?
Dysregulated prostaglandin metabolism is linked to cancer, cardiovascular disease, reproductive disorders, and chronic inflammation.
What is transcellular biosynthesis of prostaglandins?
Transcellular biosynthesis is the cooperative production of prostaglandins by different cell types, using intermediates like PGH2.
How can CRISPR be used to study prostaglandin metabolism?
CRISPR can create knockout, point mutation, knock-in, or overexpression models to dissect gene function in prostaglandin pathways.
What are prostaglandin receptors?
Prostaglandin receptors are G-protein-coupled receptors that mediate the effects of specific prostaglandins, such as PTGER1-4 for PGE2.
Why is prostaglandin metabolic process important for drug discovery?
Many drugs, including NSAIDs, target prostaglandin synthesis; understanding the pathway aids in developing safer and more effective therapies.
Conclusion
Prostaglandin metabolic process (GO:0006693) is a fundamental biological pathway with wide-ranging implications for human health and disease. From inflammation and pain to cancer and reproduction, prostaglandins exert diverse effects through a tightly regulated network of enzymes and receptors. Advances in CRISPR gene editing and screening technologies are accelerating our understanding of this pathway and enabling the development of novel therapeutics. EDITGENE is committed to supporting researchers with state-of-the-art CRISPR models and bioinformatics to unravel the complexities of prostaglandin metabolism.
References
- 1. Yang T et al.. 2022. Lipid metabolism and endometrial receptivity.. Hum Reprod Update 28(6):858-889 PMID: 35639910
- 2. Fülgraff G. 1973. [Prostaglandins].. Med Klin 68(7):195-201 PMID: 4633865
- 3. Stein-Werblowsky R. 1974. Prostaglandin and cancer.. Oncology 30(2):169-76 PMID: 4615286
- 4. Hirawa N et al.. 2004. [Prostaglandin/bradykinin].. Nihon Rinsho 62 Suppl 6:183-8 PMID: 15250292
- 7. Ferreira SH et al.. 1981. Prostaglandin hyperalgesia, IV: a metabolic process.. Prostaglandins 21(5):789-92 PMID: 6280243
- 8. Sala A et al.. 2010. Transcellular biosynthesis of eicosanoids.. Pharmacol Rep 62(3):503-10 PMID: 20631414
